Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is used to learn about the health of organisms. The unique patterns of metabolites are widely used to diagnose specific diseases. A metabolome is the terminology used in metabolomics to describe the comprehensive and quantitative analysis of all the metabolites of an organism. Metabolomics is a relatively new field of omics research compared to other similar fields such as genomics, proteomics, and transcriptomics.

TechNavio’s analysts forecast the Global Metabolomics market will grow at a CAGR of 24.26 percent over the period 2013-2018.

Covered in this Report

The Global Metabolomics market can be divided into eight segments: Mass Spectroscopy, Nuclear Magnetic Resonance Spectroscopy, Gas Chromatography, High Performance Liquid Chromatography, Metabolomics-on-a-chip, Fourier-Transform Infrared Spectroscopy, Capillary Electrophoresis, and Electrochemical Array. These are the sets of methodologies and technologies that transform unstructured and structured data into meaningful and useful information processes.

TechNavio’s report, the Global Metabolomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Metabolomics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas
• EMEA
• APAC

Key Vendors

• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corp.
• Human Metabolome Technologies Inc.
• Metabolon Inc.

Other Prominent Vendors

• Acadia Pharmaceuticals
• Accelrys
• BG Medicine
• Biocrates Life Sciences
• Chenomx
• Life Technologies
• Metabolomic Technologies
• Nanosyn
• PerkinElmer
• Waters

Key Market Driver

• Increase in Prevalence of Cancer and Diabetes
• For a full, detailed list, view our report

Key Market Challenge

• Quality Control Standards of Metabolic Profiling Data
• For a full, detailed list, view our report

Key Market Trend

• Emergence of Standards to Analyze Metabolomics Data
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation
09.1 Metabolomics Market in the Americas
09.1.1 Market Size and Forecast
09.2 Metabolomics Market in the EMEA
09.2.1 Market Size and Forecast
09.3 Metabolomics Market in the APAC
09.3.1 Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2013
17.3 Other Prominent Vendors

18. Key Vendor Analysis
18.1 Agilent Technologies
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Business Segmentation by Revenue 2013
18.1.4 Business Segmentation by Revenue 2012 and 2013
18.1.5 Sales by Geography
18.1.6 Business Strategy
18.1.7 Key Information
18.1.8 SWOT Analysis
18.1.9 Strengths
18.1.10 Weaknesses
18.1.11 Opportunities
18.1.12 Threats
18.2 Bio-Rad Laboratories
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2012
18.2.4 Business Segmentation by Revenue 2012 and 2011
18.2.5 Geographical Segmentation by Revenue 2012
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.2.9 Strengths
18.2.10 Weakness
18.2.11 Opportunities
18.2.12 Threats
18.3 Bruker
18.3.1 Key Facts
18.3.2 Business Overview/ Description
18.3.3 Business Segmentation
18.3.4 Business Strategy
18.3.5 Revenue Segmentation by Business /Products
18.3.6 Sales by Geographical Segmentation
18.3.7 Key Information
18.3.8 SWOT Analysis
18.3.9 Strengths
18.3.10 Weaknesses
18.3.11 Opportunities
18.3.12 Threats
18.4 Human Metabolome Technologies
18.4.1 Key Facts
18.4.2 Business Overview/ Description
18.4.3 Business Segmentation
18.4.4 Business Strategy
18.4.5 Revenue Segmentation by Business
18.4.6 Sales by Geographical Segmentation
18.4.7 Key Information
18.4.8 SWOT Analysis
18.4.9 Strengths
18.4.10 Weaknesses
18.4.11 Opportunities
18.4.12 Threats
18.5 Metabolon Inc.
18.5.1 Key Facts
18.5.2 Business Overview/Description
18.5.3 Business Segmentation
18.5.4 Business Strategy
18.5.5 Key Information
18.5.6 SWOT Analysis
18.5.7 02.2.1 Strengths
18.5.8 02.2.2 Weaknesses
18.5.9 02.2.3 Opportunities
18.5.10 02.2.4 Threats

19. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Metabolomics Market 2013-2018 (US$ million)
Exhibit 3: Global Metabolomics Market Segmentation by Technology
Exhibit 4: Global Metabolomics Market Segmentation by Application
Exhibit 5: Global Metabolomics Market by Geographical Segmentation 2013
Exhibit 6: Global Metabolomics market by Geographical Segmentation in 2018
Exhibit 7: Metabolomics Market in the Americas 2013-2018 (US$ million)
Exhibit 8: Metabolomics market in the EMEA region 2013-2018 (US$ million)
Exhibit 9: Metabolomics Market in the APAC region 2013-2018 (US$ million)
Exhibit 10: Agilent Technologies Inc.: Business Segmentation by Revenue 2013
Exhibit 11: Agilent Technologies Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 12: Agilent Technologies Inc.: Sales by Geography 2013
Exhibit 13: Bio-Rad Laboratories: Business Segmentation by Revenue 2012
Exhibit 14: Bio-Rad Laboratories: Business Segmentation by Revenue 2012 and 2011 (US$ million)
Exhibit 15: Bio-Rad Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 16: Business segments for Human Metabolome Technologies
Exhibit 17: Revenue Segmentation of Global Metabolomics Market 2014-2018 for 2013
Exhibit 18: Revenue Segmentation of Global Metabolomics Market 2014-2018 by Geography for 2013
Exhibit 19: Metabolon Inc. Business Segmentation